BACKGROUND AND PURPOSE: Olfactory bulb atrophy is associated with cognitive dysfunction in Parkinson's and Alzheimer's disease, and with major depression. It has been suggested that olfactory bulb atrophy or dysfunction is therefore a marker of neurodegeneration. Multiple sclerosis (MS) is now also recognized as having a significant neurodegenerative component. Thus, the aim of this study was to investigate associations between physical and cognitive disability, depression and olfactory bulb volume in MS. METHODS: In total, 146 patients with MS (mean age 49.0 \ub1 10.9 years, disease duration 21.2 \ub1 9.3 years, median Expanded Disability Status Scale (EDSS) score 3.0 (range 0-7.5), 103 relapsing-remitting, 35 secondary progressive and e...
Background: The lifetime prevalence of depression in people with multiple sclerosis (MS) is approxim...
It is unclear how cognitive impairment in multiple sclerosis (MS) is influenced by physical disabili...
Olfactory dysfunction is recognised across an ever broadening spectrum of neuropsychiatric condition...
BACKGROUND AND PURPOSE: Olfactory bulb atrophy is associated with cognitive dysfunction in Parkinson...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disabilit...
BACKGROUND: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease...
Background: The relative contribution to the olfactory dysfunction of the lesions in the specific br...
Background: Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no ...
Olfactory dysfunction is common in multiple sclerosis (MS). Olfactory bulb and tract pathology in MS...
Introduction: Previous studies have shown that olfactory functioning is affected by multiple scleros...
Background: Several studies reported olfactory dysfunction in patients with multiple sclerosis. The ...
The volume of the olfactory bulb (OB) is strongly reduced in patients with major depressive disorder...
Copyright © 2015 Domenica Nunnari et al. This is an open access article distributed under the Creati...
Background: The lifetime prevalence of depression in people with multiple sclerosis (MS) is approxim...
It is unclear how cognitive impairment in multiple sclerosis (MS) is influenced by physical disabili...
Olfactory dysfunction is recognised across an ever broadening spectrum of neuropsychiatric condition...
BACKGROUND AND PURPOSE: Olfactory bulb atrophy is associated with cognitive dysfunction in Parkinson...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disabilit...
BACKGROUND: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease...
Background: The relative contribution to the olfactory dysfunction of the lesions in the specific br...
Background: Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no ...
Olfactory dysfunction is common in multiple sclerosis (MS). Olfactory bulb and tract pathology in MS...
Introduction: Previous studies have shown that olfactory functioning is affected by multiple scleros...
Background: Several studies reported olfactory dysfunction in patients with multiple sclerosis. The ...
The volume of the olfactory bulb (OB) is strongly reduced in patients with major depressive disorder...
Copyright © 2015 Domenica Nunnari et al. This is an open access article distributed under the Creati...
Background: The lifetime prevalence of depression in people with multiple sclerosis (MS) is approxim...
It is unclear how cognitive impairment in multiple sclerosis (MS) is influenced by physical disabili...
Olfactory dysfunction is recognised across an ever broadening spectrum of neuropsychiatric condition...